title: Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy.
authors.forename: T G
authors.initials: TG
authors.lastname: Gross
authors.forename: S H
authors.initials: SH
authors.lastname: Hinrichs
authors.forename: J
authors.initials: J
authors.lastname: Winner
authors.forename: T C
authors.initials: TC
authors.lastname: Greiner
authors.forename: S S
authors.initials: SS
authors.lastname: Kaufman
authors.forename: P H
authors.initials: PH
authors.lastname: Sammut
authors.forename: A N
authors.initials: AN
authors.lastname: Langnas
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007223:Infant; D007422:Intestines / Q000637:transplantation*; D016031:Liver Transplantation / Q000009:adverse effects*; D016040:Lung Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011241:Prednisone / Q000008:administration & dosage
chemical_list: D003520:Cyclophosphamide; D011241:Prednisone